Evolva appoints Jessica Mann as Chief Medical Officer
Jessica Mann, MD, PhD has long-standing experience in drug development; she was previously Medical Director and a member of the management group of Speedel AG (sold to Novartis for USD 880 million in 2008) and prior to that worked at Roche, where she was a Senior Clinical and Licensing Liaison, and Novartis, where she was International Clinical Leader for DiovanTM. Before joining Novartis she was a Lecturer in Cardiovascular Pathology at St George’s Hospital Medical School in London. Jessica has an MD from the University of Buenos Aires and a PhD from the University of London.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.